Latest results fire Imperial Brands shares to 8-year high

Another year of impressive annual total returns continues to make the tobacco and vaping giant a popular investment. ii's head of markets runs through the numbers.

18th November 2025 08:21

by Richard Hunter from interactive investor

Share on

tobacco vape vaping smoke imperial bats 600

      There may well be a reluctance among some to invest in tobacco companies at all on ethical grounds, but this has done little to hamper a strong share price rise for Imperial Brands (LSE:IMB), let alone the group’s steady and stable growth as it repositions its offering.

      Changing lifestyle habits and tougher regulation perennially overhang this sector, but in the meantime Imperial continues to play the cards it has been dealt carefully, while also racing towards Next Generation Products (NGP) as a long-term alternative.

      However, even after some years of investment, the NGP unit is still loss-making, although there are clear signs of progress. Net revenue for the year ended 30 September grew 13.7% to £368 million, leading to cumulative growth of 83% over five years and now accounts for 11% of total revenues. The adjusted loss of £76 million represented an improvement of 1.3% as this part of the business edges towards profitability, and has lessened by 76% over five years.

      Each of the NGP categories are showing signs of traction, with Vapour being strongest in Western Europe, Heated Products in Southern and Eastern Europe and Modern Oral in the US, where its “Zone” brand is increasingly popular. By region, Europe accounts for 42% of group revenue, the Americas 35% and Africa, Australasia, Central and Eastern Europe the balancing 23%. Within these regions, the group has been tailoring specific brands to specific regions, even within countries, which has had some positive results. The group continues to focus investment in its top five combustible markets, while there have also been a number of NGP launches which have further boosted the longer-term aim of less reliance on traditional combustible products.

      Elsewhere, the tobacco majors continue to benefit from the extraordinary cash generation which their sector enables. Tobacco remains a product which has inelastic demand, providing the ability to raise prices without unduly dampening demand, and this pricing mix has seen the benefit as a result, with falling volumes more than offset by higher prices. Total group revenues remained relatively stable with a dip of just 0.7% to £32.17 billion, while adjusted operating profit grew by 4.6% to £3.99 billion, in line with estimates.

      As such, the group retains its ability to choose between shareholder returns, investment in the business, paying down debt or indeed all of these. At the present time, shareholder returns are in sharp focus, with the previously announced £1.45 billion now commenced and the previous £1.25 billion programme completed. At the same time, a further increase to the dividend lifts the current yield to 5.1%, which adds to what has been a significant boost for shareholders.

      In terms of outlook, the group is focused on adding value creation over the next five years. In the meantime, this year the group expects net revenue growth to continue in the low single digits for tobacco, by double-digits for NGP and for adjusted operating profit to increase by between 3% and 5%, while the ongoing shareholder return programme should, all things being equal, continue to underpin the share price.

      Indeed, the total return has of late been impressive for Imperial. Apart from the additional dividend bonus, the share price has risen by 33% over the last year, as compared to a gain of 19.3% for the wider FTSE100, and by 70% over the last two years while the transformation programme has been in full swing. Some strength in the price at the open, against the backdrop of a weak wider market, is also a sign of investor appreciation and the group’s defensive qualities.

      Even after the more recent rally, the shares are not obviously expensive in terms of historic valuation. Despite concerns about changing habits, a more immediate drag from some large investors either unwilling or unable to buy tobacco shares, and an imminent Budget which could leave the tobacco companies in the firing line, Imperial is navigating the current environment with aplomb. As such, the market consensus of the shares as a strong buy continues to reflect its ability to generate returns while also undergoing a major repositioning of its business.

      These articles are provided for information purposes only.  Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties.  The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.

      Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.

      Related Categories

        UK sharesEurope

      Get more news and expert articles direct to your inbox